Ibotta, Inc.
Leach Bryan (CEO AND PRESIDENT) sold 22,756 indirectly-held shares of Ibotta, Inc. (IBTA) at an average of $36.14 ($35.66–$37.41, $0.82M total) across 6 trades on 2026-08-04 under a Rule 10b5-1 trading plan.
Leach Bryan (CEO AND PRESIDENT) sold 72,274 shares of Ibotta, Inc. (IBTA) at an average of $33.69 ($24.39–$37.41, $2.43M total) across 5 trades over 2026-08-03 to 2026-08-04 under a Rule 10b5-1 trading plan.
U.S. stocks rose mid-session, with the Nasdaq up 2.22% and the S&P 500 up 1.64%. McDonald’s (NYSE:MCD) reported Q2 adjusted EPS of $3.38, above $3.32 estimates, and sales of $7.099B versus $7.128B expected. Oil fell 5.3% to $76.09 and gold rose 1.4% to $4,147.40.
Over the past 7 days, alphai's AI scored 2 news stories mentioning IBTA (Ibotta, Inc.). Coverage has skewed bullish: 1 bullish, 1 neutral, and 0 bearish.
Recent IBTA coverage spans insider activity, earnings and financial news.
In the last 30 days, IBTA insiders filed 18 SEC Form 4 transactions — no purchases and 18 sales ($4.0M). The most active reporter was Leach Bryan, CEO AND PRESIDENT, with 14 filings. 100% of activity was filed under pre-arranged Rule 10b5-1 plans.
This is a routine insider sale disclosure with no stated operational or financial change, but it can slightly affect near-term sentiment.
Insider selling is disclosed, but it is pre-arranged under a 10b5-1 plan, so it is more of a sentiment signal than a fundamental catalyst.
U.S. stocks rose mid-session, with the Nasdaq up 2.22% and the S&P 500 up 1.64%. McDonald’s (NYSE:MCD) reported Q2 adjusted EPS of $3.38, above $3.32 estimates, and sales of $7.099B versus $7.128B expected. Oil fell 5.3% to $76.09 and gold rose 1.4% to $4,147.40.
Q2 beat and a specific Q3 revenue and adjusted EBITDA outlook provide a near-term earnings model update and potential sentiment support.
Earnings are the near-term catalyst, with the article framing a revenue decline expectation and prior revenue misses as key risk factors.
alphai scores every news story that mentions IBTA with an AI model for sentiment and relevance, and aggregates insider trades from Ibotta, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Leach Bryan (CEO AND PRESIDENT) sold 22,756 indirectly-held shares of Ibotta, Inc. (IBTA) at an average of $36.14 ($35.66–$37.41, $0.82M total) across 6 trades on 2026-08-04 under a Rule 10b5-1 trading plan.
2 min readLeach Bryan (CEO AND PRESIDENT) sold 72,274 shares of Ibotta, Inc. (IBTA) at an average of $33.69 ($24.39–$37.41, $2.43M total) across 5 trades over 2026-08-03 to 2026-08-04 under a Rule 10b5-1 trading plan.
2 min readU.S. stocks rose mid-session, with the Nasdaq up 2.22% and the S&P 500 up 1.64%. McDonald’s (NYSE:MCD) reported Q2 adjusted EPS of $3.38, above $3.32 estimates, and sales of $7.099B versus $7.128B expected. Oil fell 5.3% to $76.09 and gold rose 1.4% to $4,147.40.
3 min readIbotta, Inc. (IBTA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 earningsrelease63026.htm EX-99.1 Document Ibotta Reports Second Quarter 2026 Financial Results Ibotta’s second quarter financial results exceeded the upper end of the guidance range for both revenue and adjusted EBITDA Revenue grew by 3% year-over-year to $88.9 million
6 min readIbotta (NYSE: IBTA) is set to report Q2 earnings Monday. Last quarter, it posted revenue of $82.48 million, down 2.5% YoY, and 70.69 million total redemptions, down 14.6% YoY, with an EPS miss. For this quarter, analysts expect revenue down 1.3% YoY. The average analyst price target is $33.43 versus a $24 share price.
3 min readClark Jermoluk Founders Fund I LLC sold 500,000 shares of Ibotta, Inc. (IBTA) at $30.15 ($15.08M total) on 2026-07-06.
1 min readLeach Bryan (CEO AND PRESIDENT) sold 21,895 shares of Ibotta, Inc. (IBTA) at an average of $35.21 ($34.63–$35.79, $0.77M total) across 4 trades over 2026-07-01 to 2026-07-02 under a Rule 10b5-1 trading plan.
1 min readKoch, Inc. has publicly announced a 20.7% stake in Ibotta, Inc.'s Class A common stock, filing a Schedule 13D after previously holding a Schedule 13G. This change reflects a higher percentage due to a decrease in outstanding Class A shares, not an increase in Koch's holdings, and the company maintains it is a "passive investor" with less than 10% of Ibotta’s total voting power. Koch, a privately held conglomerate, invests for long-term support of management teams rather than seeking to influence control.
2 min readKoch, Inc. and its affiliates have reported a beneficial ownership of 4,389,129 Class A common shares of Ibotta, Inc. (NYSE: IBTA), representing approximately 20.7% of the Public Shares outstanding. This significant stake arose from the reclassification of pre-IPO securities and a reduction in outstanding shares due to Ibotta's stock repurchases. The Koch group identifies as passive investors, acknowledging that Ibotta's CEO and related parties maintain majority voting control through Class B shares.
2 min readGrabar Law Office is investigating potential breaches of fiduciary duties by officers and directors of Ibotta, Inc., Lifecore Biomedical, Inc., Molina Healthcare, Inc., and WEBTOON Entertainment Inc. The law office is encouraging long-term shareholders of these companies, who purchased shares during specific periods, to contact them to seek corporate reforms and other remedies at no cost. The investigations stem from alleged misleading statements, internal control deficiencies, and other issues that affected the companies' financial projections and investor information.
4 min read
